Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Dry Powder Inhaler Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The dry powder inhaler market size has grown strongly ...
The Dry Powder Inhaler Market is poised for significant growth, with a market value of USD 20.83 billion in 2024, projected to climb to USD 29.95 billion by 2034, representing a steady CAGR of 3.70% ...
Please provide your email address to receive an email when new articles are posted on . Almost all of the estimated 1.15 MMT of CO 2 equivalent emissions in 2022 came from metered-dose inhalers. The ...
Please provide your email address to receive an email when new articles are posted on . Patients with asthma who switched from a metered-dose inhaler to a dry-powder inhaler cut their inhaler carbon ...
The Food and Drug Administration (FDA) has approved Teva's ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms.
The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 billion by 2034. The Industry is expected to surge at a CAGR of 3.70% from ...
There are various kinds of inhalers present in the market that help one to control asthma. However, each comes with its own pros and cons. If you or your loved one suffers from asthma, you know that ...
Delivering dry powders to the lungs and to the nasal cavity is gaining popularity in the pharmaceutical industry as both targets provide a large surface area for absorption, deliver drugs without ...
According to Future Market Insights, the global Dry Powder Inhaler Market is slated to exhibit a CAGR of nearly 4.6% during the forecast period (2021-2031), in terms of volume. Over 4000,000 Mn units ...
Switching from a metered-dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a ...
ProAir Digihaler ProAir Digihaler is the first digital inhaler with built-in sensors that connects to a mobile application and provides data on inhaler use to patients with asthma and chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback